163 related articles for article (PubMed ID: 27288790)
1. Upstream regulators and downstream effectors of NF-κB in Alzheimer's disease.
Shi ZM; Han YW; Han XH; Zhang K; Chang YN; Hu ZM; Qi HX; Ting C; Zhen Z; Hong W
J Neurol Sci; 2016 Jul; 366():127-134. PubMed ID: 27288790
[TBL] [Abstract][Full Text] [Related]
2. Every Cloud Has a Silver Lining: Proneurogenic Effects of Aβ Oligomers and HMGB-1 via Activation of the RAGE-NF-κB Axis.
Bortolotto V; Grilli M
CNS Neurol Disord Drug Targets; 2017; 16(10):1066-1079. PubMed ID: 27488419
[TBL] [Abstract][Full Text] [Related]
3. NF-κB as a Key Mediator of Brain Inflammation in Alzheimer's Disease.
Ju Hwang C; Choi DY; Park MH; Hong JT
CNS Neurol Disord Drug Targets; 2019; 18(1):3-10. PubMed ID: 28782486
[TBL] [Abstract][Full Text] [Related]
4. Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.
Srinivasan M; Lahiri DK
Expert Opin Ther Targets; 2015 Apr; 19(4):471-87. PubMed ID: 25652642
[TBL] [Abstract][Full Text] [Related]
5. Qifu-Yin attenuates AGEs-induced Alzheimer-like pathophysiological changes through the RAGE/NF-κB pathway.
Wang SY; Liu JP; Ji WW; Chen WJ; Fu Q; Feng L; Ma SP
Chin J Nat Med; 2014 Dec; 12(12):920-8. PubMed ID: 25556063
[TBL] [Abstract][Full Text] [Related]
6. Nicotinamide treatment reduces the levels of oxidative stress, apoptosis, and PARP-1 activity in Aβ(1-42)-induced rat model of Alzheimer's disease.
Turunc Bayrakdar E; Uyanikgil Y; Kanit L; Koylu E; Yalcin A
Free Radic Res; 2014 Feb; 48(2):146-58. PubMed ID: 24151909
[TBL] [Abstract][Full Text] [Related]
7. The protein arginine methyltransferase PRMT5 regulates Aβ-induced toxicity in human cells and Caenorhabditis elegans models of Alzheimer's disease.
Quan X; Yue W; Luo Y; Cao J; Wang H; Wang Y; Lu Z
J Neurochem; 2015 Sep; 134(5):969-77. PubMed ID: 26086249
[TBL] [Abstract][Full Text] [Related]
8. [Effects of tanshinone IIA on the expressions of caspase-3, Akt and NF-κB in the brains of rat models of Alzheimer's disease].
Wen P; Luo H; Zhou L; Song Z; Li W; Zhou J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Feb; 30(2):155-9. PubMed ID: 24491056
[TBL] [Abstract][Full Text] [Related]
9. Reactive oxygen species, redox signaling and neuroinflammation in Alzheimer's disease: the NF-κB connection.
Kaur U; Banerjee P; Bir A; Sinha M; Biswas A; Chakrabarti S
Curr Top Med Chem; 2015; 15(5):446-57. PubMed ID: 25620241
[TBL] [Abstract][Full Text] [Related]
10. Increased NF-κB signalling up-regulates BACE1 expression and its therapeutic potential in Alzheimer's disease.
Chen CH; Zhou W; Liu S; Deng Y; Cai F; Tone M; Tone Y; Tong Y; Song W
Int J Neuropsychopharmacol; 2012 Feb; 15(1):77-90. PubMed ID: 21329555
[TBL] [Abstract][Full Text] [Related]
11. Xylocoside G reduces amyloid-β induced neurotoxicity by inhibiting NF-κB signaling pathway in neuronal cells.
Yu Y; Zhou L; Sun M; Zhou T; Zhong K; Wang H; Liu Y; Liu X; Xiao R; Ge J; Tu P; Fan DS; Lan Y; Hui C; Chui D
J Alzheimers Dis; 2012; 30(2):263-75. PubMed ID: 22430528
[TBL] [Abstract][Full Text] [Related]
12. UNVEILING THE COMPLEX ROLE OF NF-ΚB IN ALZHEIMER'S DISEASE: INSIGHTS INTO BRAIN INFLAMMATION AND POTENTIAL THERAPEUTIC TARGETS.
Verma Y; Sachdeva H; Kalra S; Kumar P; Singh G
Georgian Med News; 2023 Sep; (342):133-141. PubMed ID: 37991969
[TBL] [Abstract][Full Text] [Related]
13. Strong nuclear factor-kappaB-DNA binding parallels cyclooxygenase-2 gene transcription in aging and in sporadic Alzheimer's disease superior temporal lobe neocortex.
Lukiw WJ; Bazan NG
J Neurosci Res; 1998 Sep; 53(5):583-92. PubMed ID: 9726429
[TBL] [Abstract][Full Text] [Related]
14. Aβ-AGE aggravates cognitive deficit in rats via RAGE pathway.
Chen C; Li XH; Tu Y; Sun HT; Liang HQ; Cheng SX; Zhang S
Neuroscience; 2014 Jan; 257():1-10. PubMed ID: 24188791
[TBL] [Abstract][Full Text] [Related]
15. Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.
Seo EJ; Fischer N; Efferth T
Pharmacol Res; 2018 Mar; 129():262-273. PubMed ID: 29179999
[TBL] [Abstract][Full Text] [Related]
16. Nuclear Factor Kappa-light-chain-enhancer of Activated B Cells (NF-κB) - a Friend, a Foe, or a Bystander - in the Neurodegenerative Cascade and Pathogenesis of Alzheimer's Disease.
Marwarha G; Ghribi O
CNS Neurol Disord Drug Targets; 2017; 16(10):1050-1065. PubMed ID: 28745240
[TBL] [Abstract][Full Text] [Related]
17. Suppression of nuclear factor kappa B ameliorates astrogliosis but not amyloid burden in APPswe/PS1dE9 mice.
Zhang X; Luhrs KJ; Ryff KA; Malik WT; Driscoll MJ; Culver B
Neuroscience; 2009 Jun; 161(1):53-8. PubMed ID: 19286451
[TBL] [Abstract][Full Text] [Related]
18. Quercetin disrupts tyrosine-phosphorylated phosphatidylinositol 3-kinase and myeloid differentiation factor-88 association, and inhibits MAPK/AP-1 and IKK/NF-κB-induced inflammatory mediators production in RAW 264.7 cells.
Endale M; Park SC; Kim S; Kim SH; Yang Y; Cho JY; Rhee MH
Immunobiology; 2013 Dec; 218(12):1452-67. PubMed ID: 23735482
[TBL] [Abstract][Full Text] [Related]
19. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
Chen Z; Zhong C
Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
[TBL] [Abstract][Full Text] [Related]
20. A specific RAGE-binding peptide biopanning from phage display random peptide library that ameliorates symptoms in amyloid β peptide-mediated neuronal disorder.
Cai C; Dai X; Zhu Y; Lian M; Xiao F; Dong F; Zhang Q; Huang Y; Zheng Q
Appl Microbiol Biotechnol; 2016 Jan; 100(2):825-35. PubMed ID: 26496918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
